Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.

Cancer biotherapy & radiopharmaceuticals - 1 Mar 2021

Liu Chang-Rui, Meng Fan-Hua

Abstract excerpt

Purpose: The authors explore the role of DNASE1L2 in breast cancer (BC) and its affect on the cell phenotype. Methods: Breast invasive ductal carcinoma RNA-Seq data set was downloaded from The Cancer Genome Atlas database for analyzing DNASE1L2 levels. Overall survival curve was plotted by Kaplan-Meier methods. The correlations between DNASE1L2 expression and clinical characteristics were analyzed by chi-square...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Deoxyribonuclease I

Share to Epithelial-Mesenchymal Transition

Share to Phenotype

Share to Prognosis

Share to Transfection

Source

Identifiers

PMID: 32343605
DOI: 10.1089/cbr.2019.3504

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.PMID 32343605Read ↗

GREB1L overexpression associates with good clinical outcomes in breast cancerSemantic proximity Read ↗

LncRNA DDX11-AS1 promotes breast cancer progression via targeting the miR-30c-5p/MTDH axisSemantic proximity Read ↗

DDB2: A Novel Regulator of NF-κB and Breast Tumor InvasionSemantic proximity Read ↗

Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionSemantic proximity Read ↗

LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) PhenotypeSemantic proximity Read ↗

The Expression of CLDN11 in Invasive Ductal and Invasive Lobular Breast Cancer and Multivariate Prognostic AnalysisSemantic proximity Read ↗

Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B PathwaySemantic proximity Read ↗

Exploring ID4 as a Driver of Aggression and a Therapeutic Target in Triple-Negative Breast CancerSemantic proximity Read ↗

The dysregulation of NME1, LINC00511, and LINC01028 could disturb the regular apoptosis process and promote breast cancer in the Isfahan population: integrated bioinformatics and experimental analysesSemantic proximity Read ↗

A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma.Semantic proximity Read ↗

Exosomal circ‐0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axisSemantic proximity Read ↗

Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatmentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.